Lack of response of alopecia areata to pimecrolimus cream [11]

Clinical and Experimental Dermatology

Volumn 32, Issue 4, 2007, Pages 456-457

  Rigopoulos, D ^a   Gregoriou, S ^a   Korfitis, C ^a   Gintzou, C ^a   Vergou, T ^a   Katrinaki, A ^a   Kalogeromitros, D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEXPANTHENOL; PIMECROLIMUS; PLACEBO;

ADOLESCENT; ADULT; ALOPECIA AREATA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DEMOGRAPHY; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; PATIENT SELECTION; PRIORITY JOURNAL; TOPICAL TREATMENT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALOPECIA AREATA; DERMATOLOGIC AGENTS; EMOLLIENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PILOT PROJECTS; TACROLIMUS;

EID: 34249727780     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02367.x     Document Type: Letter

References (5)

1. McElwee KJ, Rushton DH, Trachy R, Oliver RF. Topical FK506: a potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model. Br J Dermatol 1997 137 : 491 7.
2. Freyschmidt-Paul P, Ziegler A, McElwee KJ et al. Treatment of alopecia in C3H/HEJ mice with the topical immunosuppressant FK506 (tacrolimus). Eur J Dermatol 2001 11 : 405 9.
3. Price VH, Willey A, Chen BK. Topical tacrolimus in alopecia areata. J Am Acad Dermatol 2005 52 : 138 9.
4. Feldmann KA, Kunte C, Wollenberg A, Wolff H. Is topical tacrolimus effective in alopecia areata universalis? Br J Dermatol 2002 147 : 1031 2.
5. Olsen E, Hordinsky M, McDonald-Hull S et al. Alopecia areata investigational assessment guidelines. J Am Acad Dermatol 1999 40 : 242 6.